Inhibition of Growth and Metastases of Inoculated Human Prostate Cancer in Nude Mice by Antisense Vascular Endothelial rowth Factor

Wei SU,Qi-yin WANG,Ming Guan

DOI: https://doi.org/10.3969/j.issn.1672-8467.2005.05.020

2005-01-01

Abstract:Purpose Effect of antisense vascular endothelial growth factor was studied in prostate cancer LNCaP C42 cells biological features such as,proliferation and invasion in vitro and in vivo. Methods Tumor cells proliferation with antisense VEGF were detected by MTT analysis in vitro.In vivo,the tumor cells transfected with antisense VEGF were injected sc into nude mice.The tumor volume (mm3) wasmeasured by using a caliper,applying the formula [volume=0.52×(width)2×(length)] for approximating the volume of a spheroid.Intratumoral microvessel density (MVD) were detected by immunohistochemistry using mouse anti-human CD31 monoclonal antibody,and lung metastases nodule are evaluated using HE stai- ning. Results Prostate cancer LNCaP C42 proliferation was inhibited by antisense VEGF in vitro.In compared with the controls,growth of the implanted tumor was significantly reduced in sizes in mice transfected with antisense VEGF.The MVD decreased significantly in the mice transfected with antisense VEGF [(31±3.25) versus (14.25±3.40),P0.05],and the lung metastases were also significantly inhibited. Conclusions Antisense VEGF has a strong inhibitory effect both on tumor growth and metastases of human prostate cancer in vitro and in vivo by inhibiting tumor angiogenesis.It was suggested that inhibition of VEGF is a valuable therapeutic way in prostate cancer.